Published in J Immunol on June 01, 1991
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis (1993) 1.98
Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev (1995) 1.95
Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med (1995) 1.83
A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest (1993) 1.66
Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 1.65
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun (1992) 1.37
Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun (1996) 1.35
Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol (2003) 1.23
Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun (1997) 1.16
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest (1995) 1.10
Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med (1993) 1.07
Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J (1999) 1.06
Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect Immun (1992) 1.01
Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun (2005) 0.93
Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun (2007) 0.90
Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun (1993) 0.90
Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens. Infect Immun (1996) 0.90
Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals. J Exp Med (1994) 0.87
Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo. Clin Exp Immunol (1994) 0.85
Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes. Immunology (1997) 0.81
Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect Immun (1996) 0.81
Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein. Infect Immun (1994) 0.80
Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect Immun (1998) 0.80
Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism. Immunology (2002) 0.80
Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B. J Clin Microbiol (1999) 0.79
Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli. Infect Immun (1997) 0.78
Functional and structural properties of a novel protein and virulence factor (Protein sHIP) in Streptococcus pyogenes. J Biol Chem (2014) 0.77
Streptococcal exotoxin B increases interleukin-6, tumor necrosis factor alpha, interleukin-8 and transforming growth factor beta-1 in leukocytes. Pediatr Nephrol (2007) 0.77
In vivo and in vitro detection of a superantigenic toxin Vbeta signature in two forms of streptococcal toxic shock syndrome. Eur J Clin Microbiol Infect Dis (2008) 0.76
HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus. J Biomed Biotechnol (2005) 0.76
The gene encoding a new mitogenic factor in a Streptococcus pyogenes strain is distributed only in group A streptococci. Infect Immun (1994) 0.75
Structure and Interactions of a Dimeric Variant of sHIP, a Novel Virulence Determinant of Streptococcus pyogenes. Front Microbiol (2016) 0.75
HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr Nephrol (2006) 0.75
Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med (1970) 7.27
Lay perspectives: advantages for health research. BMJ (1998) 5.44
Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy (2007) 4.52
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 4.19
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
Evidence for the effects of a superantigen in rheumatoid arthritis. Science (1991) 3.71
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis (1998) 3.69
Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity (2001) 3.18
Autoimmune disease: why and where it occurs. Nat Med (2001) 3.04
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation (1994) 2.80
The revised two-factor Study Process Questionnaire: R-SPQ-2F. Br J Educ Psychol (2001) 2.72
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med (1990) 2.71
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med (1997) 2.64
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) (2004) 2.54
Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med (1997) 2.38
Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol (1992) 2.29
The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med (1988) 2.23
Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (1976) 2.17
Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol (1998) 2.14
Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest (1984) 2.10
Immunology of the eye and the joint. Immunol Today (1994) 2.10
Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol (1993) 2.09
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Di- and trinucleotide target preferences of somatic mutagenesis in normal and autoreactive B cells. J Immunol (1996) 2.08
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet (1994) 2.00
Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest (1994) 1.98
Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med (1988) 1.97
Onset and persistence of childhood asthma: predictors from infancy. Pediatrics (2001) 1.91
Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum (1996) 1.88
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol (1998) 1.87
Characteristics of hydrocarbon uptake in cultures with two liquid phases. Biotechnol Bioeng (1977) 1.85
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol (1997) 1.75
Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis (2000) 1.74
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol (1994) 1.70
Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy (2010) 1.70
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Microbial extracellular glycolipid induction of differentiation and inhibition of the protein kinase C activity of human promyelocytic leukemia cell line HL60. Biosci Biotechnol Biochem (1997) 1.67
The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. J Exp Med (1987) 1.64
Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol (1995) 1.64
Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol (1999) 1.62
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol (1996) 1.60
Production of IgE-potentiating factor in man by T cell lines bearing Fc receptors for IgE. Eur J Immunol (1984) 1.59
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med (1997) 1.58
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A (2000) 1.57
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol (2000) 1.56
Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J (1997) 1.53
Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol (1996) 1.52
Monoclonal anti-histone autoantibodies derived from murine models of lupus. J Immunol (1984) 1.52
Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol (1994) 1.52
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med (1991) 1.51
Localization of antigenic determinants in the polypeptide chains of collagen. Science (1969) 1.51
Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol (1998) 1.50
Nerve fibres in optic nerve of rat. Nature (1967) 1.49
18F-FDG PET detection of colonic adenomas. J Nucl Med (2001) 1.49
In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol (1996) 1.48
Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J (1996) 1.48
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med (1998) 1.47
Induction of human IgE synthesis by a factor derived from T cells of patients with hyper-IgE states. J Immunol (1983) 1.46
The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am (2000) 1.46
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol (1983) 1.46
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol (1995) 1.44
Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol (1996) 1.43
Genetic basis of systemic lupus erythematosus. Curr Opin Immunol (1996) 1.43
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (1999) 1.43
The Lancet's Analytical Sanitary Commission. Lancet (1979) 1.42
Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med (1990) 1.41
High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med (2001) 1.39
Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun (2007) 1.39
Superantigens: biology, immunology, and potential role in disease. J Clin Immunol (1992) 1.38
'A cure with a defect': a previously unpublished letter by Freud concerning 'Anna O.'. Int J Psychoanal (1999) 1.38
Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol (1994) 1.38
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation (1973) 1.36
Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol (1992) 1.36
Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A (1994) 1.35
Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med (1985) 1.35
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Metropolitan home living conditions associated with indoor endotoxin levels. J Allergy Clin Immunol (2001) 1.33
Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol (1995) 1.33
Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med (1995) 1.31
Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1983) 1.31
The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol (1999) 1.30
Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol (1999) 1.29
Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci U S A (1993) 1.29
A large deletion within the T-cell receptor beta-chain gene complex in New Zealand white mice. Science (1985) 1.27
A new smoking cessation programme using the Internet. Tob Control (1999) 1.26